|
|
||||||||||||||
|
|
|||||||||||||||
Debate
|
| FDA REGULATION |
Correspondence to:
Stan Shatenstein
shatensteins@sympatico.ca
Keywords: Food and Drug Administration; FDA; tobacco products
| The first 150 words of the full text of this article appear below. |
This past July, the US Senate voted 78 to 15 to grant the Food and Drug Administration (FDA) authority to regulate tobacco products. The proposed, precedent setting legislation is part of a larger tax bill and is also tied to a controversial tobacco growers buyout. In order to become law, the Senate version of the Bill, sponsored by Republican Senator Mike DeWine of Ohio and Democrat Edward Kennedy of Massachusetts, must be harmonised with a proposed, far weaker House of Representatives Bill that does not include FDA regulation. Ultimate passage of a revised Bill is not likely to occur until some time in 2005, if at all. If key senators carry out their threat to block passage of watered down House legislation, the regulatory debate may have to wait for another day, or year.
Among its many provisions, the Senate version of the Bill:
This article has been cited by other articles:
![]() |
D. T. Studlar Unfiltered: Conflicts over Tobacco Policy and Public Health; Smoke in Their Eyes: Lessons in Movement Leadership from the Tobacco Wars; The Fight Against Big Tobacco: The Movement, the State, and the Public's Health Journal of Health Politics Policy and Law, April 1, 2006; 31(2): 395 - 407. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |